| Univariate analyses | Multivariate analyses | ||
---|---|---|---|---|
HR (95% CI) | P value | HR (95% CI) | P value | |
Age (years, > 60/≤60) | 0.925 (0.687–1.245) | 0.606 |  |  |
Gender (male/female) | 0.872 (0.640–1.188) | 0.386 |  |  |
Tumor length (cm, > 3.0/≤3.0) | 1.266 (0.919–1.745) | 0.149 |  |  |
Tumor location | ||||
 middle/upper | 1.175 (0.609–2.266) | 0.631 |  |  |
 lower/upper | 1.149 (0.598–2.209) | 0.677 |  |  |
Vessel invasion (yes/no) | 1.657 (1.149–2.388) | 0.007 |  |  |
Perineural invasion (yes/no) | 1.564 (1.116–2.193) | 0.009 |  |  |
Differentiation | ||||
 moderate/well | 1.146 (0.745–1.762) | 0.534 |  |  |
 poor/well | 1.334 (0.796–2.236) | 0.274 |  |  |
TNM stage | ||||
 II/I | 1.723 (1.150–2.582) | 0.008 | 1.814 (1.200–2.743) | 0.005 |
 III/I | 2.555 (1.734–3.765) | < 0.001 | 1.981 (1.317–2.980) | < 0.001 |
Adjuvant treatment (yes/no) | 1.099 (0.796–1.516) | 0.567 |  |  |
PNI (> 47.5/≤47.5) | 0.534 (0.398–0.717) | < 0.001 |  |  |
SII (> 588/≤588) | 1.816 (1.334–2.471) | < 0.001 | 1.445 (1.046–1.997) | 0.026 |
OPS | ||||
 1/0 | 1.865 (1.272–2.735) | 0.001 | 1.938 (1.310–2.868) | 0.001 |
 2/0 | 3.043 (1.960–4.725) | < 0.001 | 2.757 (1.762–4.315) | < 0.001 |
 3/0 | 5.744 (3.090–10.676) | < 0.001 | 4.779 (2.499–9.140) | < 0.001 |
GPS | ||||
 1/0 | 2.092 (1.507–2.906) | < 0.001 |  |  |
 2/0 | 3.435 (2.158–5.469) | < 0.001 |  |  |
SIS | ||||
 1/0 | 1.637 (1.207–2.221) | 0.002 |  |  |
 2/0 | 1.914 (1.084–3.379) | 0.025 |  |  |